1. Home
  2. GEHC vs STZ Comparison

GEHC vs STZ Comparison

Compare GEHC & STZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEHC
  • STZ
  • Stock Information
  • Founded
  • GEHC 1892
  • STZ 1945
  • Country
  • GEHC United States
  • STZ United States
  • Employees
  • GEHC N/A
  • STZ N/A
  • Industry
  • GEHC Computer Software: Prepackaged Software
  • STZ Beverages (Production/Distribution)
  • Sector
  • GEHC Technology
  • STZ Consumer Staples
  • Exchange
  • GEHC Nasdaq
  • STZ Nasdaq
  • Market Cap
  • GEHC 37.5B
  • STZ 41.2B
  • IPO Year
  • GEHC N/A
  • STZ 1987
  • Fundamental
  • Price
  • GEHC $78.91
  • STZ $227.37
  • Analyst Decision
  • GEHC Buy
  • STZ Buy
  • Analyst Count
  • GEHC 13
  • STZ 19
  • Target Price
  • GEHC $95.46
  • STZ $284.53
  • AVG Volume (30 Days)
  • GEHC 3.3M
  • STZ 1.7M
  • Earning Date
  • GEHC 02-13-2025
  • STZ 01-09-2025
  • Dividend Yield
  • GEHC 0.18%
  • STZ 1.77%
  • EPS Growth
  • GEHC 8.27
  • STZ N/A
  • EPS
  • GEHC 3.65
  • STZ 3.16
  • Revenue
  • GEHC $19,559,000,000.00
  • STZ $10,190,800,000.00
  • Revenue This Year
  • GEHC $2.72
  • STZ $5.21
  • Revenue Next Year
  • GEHC $4.08
  • STZ $6.23
  • P/E Ratio
  • GEHC $21.62
  • STZ $72.10
  • Revenue Growth
  • GEHC 1.43
  • STZ 4.14
  • 52 Week Low
  • GEHC $71.31
  • STZ $224.76
  • 52 Week High
  • GEHC $94.55
  • STZ $274.87
  • Technical
  • Relative Strength Index (RSI)
  • GEHC 36.91
  • STZ 34.59
  • Support Level
  • GEHC $80.47
  • STZ $237.49
  • Resistance Level
  • GEHC $81.78
  • STZ $245.31
  • Average True Range (ATR)
  • GEHC 1.56
  • STZ 4.64
  • MACD
  • GEHC -0.26
  • STZ -1.42
  • Stochastic Oscillator
  • GEHC 31.35
  • STZ 4.63

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).

About STZ Constellation Brands Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the us, generating 82% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company continue to prune assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the us, the firm has little revenue exposure to international markets. Constellation owns a 26% stake in no-moat Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

Share on Social Networks: